opentargets-database

To query target-disease associations, you use the Open Targets GraphQL API to retrieve genetic, pathway, and clinical evidence. This approach supports target discovery, assessment, and drug repurposing workflows by mapping disease relationships programmatically.

Retrieving genetic and clinical evidence for drug repurposing involves querying the Open Targets Platform to map known drugs to diseases. You can aggregate target annotations and evidence types to identify alternative therapeutic opportunities and inform research decisions.

Yes, you can fetch disease information and associated drug data with Python using a reusable helper module. This module queries the Open Targets GraphQL API to aggregate drug relationships and target annotations for your research projects.

Yes, the Open Targets GraphQL API requires the Python requests library for evidence retrieval and executing queries. This dependency handles the HTTP communication needed to fetch target-disease associations and drug information from the platform.

To prioritize targets across multiple evidence types, you query the Open Targets API to combine genetic, pathway, and clinical data. Aggregating these evidence types allows you to score and rank target-disease associations for target assessment.

Limitations of using GraphQL for target-disease mapping include handling complex query structures and managing large evidence retrieval payloads within Python. You must structure GraphQL queries precisely to avoid incomplete data returns from the Open Targets Platform.